ATMPs can be classified as either gene therapies, somatic cell therapies, tissue engineered products or combined ATMPs

EMA revises what it classifies as advanced-therapy treatments

By Zachary Brennan

The European Medicines Agency’s Committee for Advanced Therapies (CAT) has revised a reflection paper on the classification of advanced-therapy medicinal products (ATMPs) to reflect cases in which medicines can be classified as ATMPs. 

New 1000L SUB at Cobra's facility in Södertälje, Sweden

Cobra's French mAb customers to get R&D tax credit

By Gareth Macdonald

French mAb developers that hire Cobra Biologics stand to benefit from tax breaks after the French Ministry of Higher Education and Research (MESR) named the CMO as a preferred provider.


Follow us


View more


Featured Suppliers

All suppliers